Shizuoka, Japan

Ryuichiro Nakai

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Tokyo, JP (1998)
  • Machida, JP (1999)
  • San Diego, CA (US) (2010)
  • Shizuoka, JP (2008 - 2011)
  • Mishima, JP (2017)

Company Filing History:


Years Active: 1998-2017

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Ryuichiro Nakai: Innovator in Pharmaceutical Patents

Introduction

Ryuichiro Nakai is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on developing innovative therapeutic agents that address critical medical needs.

Latest Patents

Among his latest patents, Nakai has developed a Wnt signaling inhibitor. This inhibitor comprises a fused-ring heterocyclic compound, which serves as an active ingredient. Additionally, he has created a therapeutic agent for restenosis, utilizing a thiadiazoline derivative. These inventions highlight his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Nakai has worked with notable companies such as Kyowa Hakko Kirin Co., Limited and Kyowa Hakko Kogyo Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Throughout his career, Nakai has collaborated with esteemed colleagues, including Yoshinori Yamashita and Chikara Murakata. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ryuichiro Nakai's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his dedication to innovation. His work continues to impact the medical community positively, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…